日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: De Novo Cost‑Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation

更正:非酒精性脂肪性肝炎的全新成本效益模型框架——建模方法和验证

Gal, Peter; Feldmajer, Gyorgyi; Augusto, Margarida; Gani, Ray; Hook, Emma; Bullement, Ash; Philips, Zoe; Smith, Inger

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy

意大利含西妥昔单抗方案治疗头颈部鳞状细胞癌的成本效益分析

Ivanyi, Philipp; Bullement, Ash; Botticelli, Andrea; Perri, Francesco; Colombo, Giorgio L; Annibali, Viviana; Gandola, Anita; Naik, Jaesh; Schlichting, Michael; Pescott, Chris P

"Don't keep me waiting": estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes

“别让我等太久”:评估静脉输液时间缩短对美国3L+ LBCL患者终生预后的影响

Vadgama, Sachin; Pasquini, Marcelo C; Maziarz, Richard T; Hu, Zhen-Huan; Ray, Markqayne; Smith, Harry; Bullement, Ash; Edmondson-Jones, Mark; Sullivan, Will; Cartron, Guillaume

De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation

非酒精性脂肪性肝炎的全新成本效益模型框架——建模方法及验证

Gal, Peter; Feldmajer, Gyorgyi; Augusto, Margarida; Gani, Ray; Hook, Emma; Bullement, Ash; Philips, Zoe; Smith, Inger

A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment

将外部证据纳入基于试验的生存率外推法进行卫生技术评估的方法系统评价

Bullement, Ash; Stevenson, Matthew D; Baio, Gianluca; Shields, Gemma E; Latimer, Nicholas R

What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches

肿瘤学中用于评估健康状态效用值的分析方法对质量调整生命年(QALY)有何影响?一项比较基于疾病进展和基于死亡时间两种方法的模拟研究

Hatswell, Anthony J; Bullement, Ash; Schlichting, Michael; Bharmal, Murtuza

Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States

美国重度血友病A(无抑制因子)患者rFVIIIFc与现有rFVIII疗法的成本效益分析

Bullement, Ash; Knowles, Emma S; DasMahapatra, Pronabesh; Ali, Talaha; Preblick, Ron

Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data

意大利重度血友病A患者使用重组VIII因子Fc融合蛋白(rFVIIIFc)治疗的成本效益分析:纳入真实世界给药和关节健康数据

Bullement, Ash; McMordie, Samuel Thomas; Hatswell, Anthony James; Li, Nanxin; Wilson, Koo

MON-335 Phenocopy of Multiple Endocrine Neoplasia Type 1 (MEN1) Due to a Germline Cell Division Cycle 73 (CDC73) Variant

MON-335 表型模拟 1 型多发性内分泌肿瘤 (MEN1),由生殖系细胞分裂周期 73 (CDC73) 变异引起

Bullement, Ash; Willis, Anna; Amin, Amerah; Schlichting, Michael; Hatswell, Anthony James; Bharmal, Murtuza; Kundu, Somanath; Mitra, Soham; Arivazhagan, Roshini; Longo, John; Longo, Sharon; Venskus, Abigail; Babu, Harish; Viapiano, Mariano; Yamamura, Toshihiro; Tamura, Kaoru; Kobayashi, Daisuke; Inaji, Motoki; Toyama, Yuka; Hara, Shoko; Tanaka, Yoji; Nariai, Tadashi; Kiyokawa, Juri; Ishii, Kenji; Maehara, Taketoshi; Amin, Samirkumar; Kang, Wonyeong; Gujar, Amit; Maher, Leigh; Courtois, Elise; Robson, Paul; Dickinson, Peter; Packer, Rebecca; Lee, Charles; Verhaak, Roel; Kirkpatrick, John; Franklin, Heather; Torok, Jordan; Floyd, Scott; Anders, Carey; Fecci, Peter; Salama, April; Clarke, Jeffrey; George, Daniel; Crapo, James; Peters, Katherine; Lin, Amy; Yagiz, Kader; Hofacre, Andrew; Munday, Anthony; Espinoza, Fernando Lopez; Mendoza, Daniel; Burrascano, Cynthia; Gruber, Harry; Mitchell, Leah; Jolly, Douglas; Lines, Kate; Nachtigall, Lisa; Dichtel, Laura; Cranston, Treena; Khairi, Shafaq; Boon, Hannah; Abedi, Parisa; Zhang, Xun; Kooblall, Kreepa; Stevenson, Mark; Klibanski, Anne; Thakker, Rajesh

A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments

癌症治疗经济价值评估中近期决策分析模型综述

Bullement, Ash; Cranmer, Holly L; Shields, Gemma E